@askrenal (@askrenal) 's Twitter Profile
@askrenal

@askrenal

Crowdsourcing answers to Nephrology questions!
A @nephjc initiative, based @UAlberta #Academic a/c.
Bot Questions? DM - @dr_nikhilshah

ID: 807056923103109120

linkhttp://nephjc.com calendar_today09-12-2016 02:58:59

8,8K Tweet

9,9K Followers

112 Following

@askrenal (@askrenal) 's Twitter Profile Photo

Question for #NephX #NephTwitter - DrPallaviPrasad: Senthil Kumar @askrenal The G1A1 just helps to classify them as low risk...but not "no risk" x.com/DrPallaviPrasa…

@askrenal (@askrenal) 's Twitter Profile Photo

Question for #NephX #NephTwitter - diplomaticdoc: Pallavi Prasad MD DNB @askrenal According to definition that's a clear yes mam. But I'm just worried about the tag/brand of ckd on them if it's really required. If it's going to be progressive it's fine, but … x.com/diplomaticdoc/…

@askrenal (@askrenal) 's Twitter Profile Photo

Question for #NephX #NephTwitter - diplomaticdoc: Pallavi Prasad MD DNB @askrenal A disease like Thin Basement Disease, though has abnormalities on histology and persistent haematuria, technically come under CKD but is not going to be progressive so in that … x.com/diplomaticdoc/…

@askrenal (@askrenal) 's Twitter Profile Photo

Question for #NephX #NephTwitter - diplomaticdoc: Pallavi Prasad MD DNB @askrenal But yes, mam. I guess AAV or LN in remission could still progress to CKD. Apparently, even Bartter’s syndrome has a risk of progression to ckd. pmc.ncbi.nlm.nih.gov/articles/PMC10… Even … x.com/diplomaticdoc/…

@askrenal (@askrenal) 's Twitter Profile Photo

Question for #NephX #NephTwitter - CajinaCarmen: 🚨🚨🚨 Looking for some help -When you suspect 5-oxoproline AGMA, do you go with urine or serum 5-oxoproline? Or both? Do you usually check glutathione too? #NephTwitter #Nephrology #MedEd #askrenal 𝅙… x.com/CajinaCarmen/s…

@askrenal (@askrenal) 's Twitter Profile Photo

Question for #NephX #NephTwitter - GlassockJ: Kenar Jhaveri Sayna Norouzi, MD, FASN @askrenal Deepa Malieckal MD Eculuzumab but not avacopan has been used with uncertain benefits added to SOC. Complenent activation and MAC fornafion are involved in glomerular injury. x.com/GlassockJ/stat…